CCL4 and Alzheimer disease: On the contrary, expression of CCL4 in D3 lysates in the BBB model was increased by 159.70-fold, 134.74-fold and 172.27-fold with control, mild AD and moderate AD patients respectively, compared to BBB models without PBMCs (Table 2).